The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Botanical Drug Market Research Report 2025
Synopsis
A botanical drug product is intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in humans.
A botanical drug product consists of vegetable materials, which may include plant materials, algae, macroscopic fungi, or combinations thereof.
A botanical drug product may be available as (but not limited to) a solution, powder, tablet, capsule, elixir, topical, or injection.
Botanical drug products often have unique features, for example, complex mixtures, lack of a distinct active ingredient, and substantial prior human use. Fermentation products and highly purified or chemically modified botanical substances are not considered botanical drug products.
The global Botanical Drug market was valued at US$ 36500 million in 2023 and is anticipated to reach US$ 50500 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
Global 5 largest manufacturers of Botanical Drug are Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe and Tong Ren Tang, which make up about 30%.
China is the largest market, with a share over 60%. In terms of product type, OTC occupy the largest share of the total market, over 60%. And in terms of application, the largest application is Cardiovascular, followed by Respiratory System and Tumor.
This report aims to provide a comprehensive presentation of the global market for Botanical Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Botanical Drug.
Report Scope
The Botanical Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Botanical Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Botanical Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Buchang Pharmaceuticals
China TCM
Tsumura
Schwabe
Tong Ren Tang
Jumpcan Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Yunnan Baiyao
Tasly Holding Group
Bionorica Se
Huarun 999
Taiji
Weleda
Kwangdong
GW Pharmaceuticals
Segment by Type
Prescription Drug
OTC
Segment by Application
Cardiovascular
Tumor
Respiratory System
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Botanical Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A botanical drug product is intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in humans.
A botanical drug product consists of vegetable materials, which may include plant materials, algae, macroscopic fungi, or combinations thereof.
A botanical drug product may be available as (but not limited to) a solution, powder, tablet, capsule, elixir, topical, or injection.
Botanical drug products often have unique features, for example, complex mixtures, lack of a distinct active ingredient, and substantial prior human use. Fermentation products and highly purified or chemically modified botanical substances are not considered botanical drug products.
The global Botanical Drug market was valued at US$ 36500 million in 2023 and is anticipated to reach US$ 50500 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
Global 5 largest manufacturers of Botanical Drug are Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe and Tong Ren Tang, which make up about 30%.
China is the largest market, with a share over 60%. In terms of product type, OTC occupy the largest share of the total market, over 60%. And in terms of application, the largest application is Cardiovascular, followed by Respiratory System and Tumor.
This report aims to provide a comprehensive presentation of the global market for Botanical Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Botanical Drug.
Report Scope
The Botanical Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Botanical Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Botanical Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Buchang Pharmaceuticals
China TCM
Tsumura
Schwabe
Tong Ren Tang
Jumpcan Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Yunnan Baiyao
Tasly Holding Group
Bionorica Se
Huarun 999
Taiji
Weleda
Kwangdong
GW Pharmaceuticals
Segment by Type
Prescription Drug
OTC
Segment by Application
Cardiovascular
Tumor
Respiratory System
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Botanical Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Botanical Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Prescription Drug
1.2.3 OTC
1.3 Market by Application
1.3.1 Global Botanical Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cardiovascular
1.3.3 Tumor
1.3.4 Respiratory System
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Botanical Drug Market Perspective (2019-2030)
2.2 Botanical Drug Growth Trends by Region
2.2.1 Global Botanical Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Botanical Drug Historic Market Size by Region (2019-2024)
2.2.3 Botanical Drug Forecasted Market Size by Region (2025-2030)
2.3 Botanical Drug Market Dynamics
2.3.1 Botanical Drug Industry Trends
2.3.2 Botanical Drug Market Drivers
2.3.3 Botanical Drug Market Challenges
2.3.4 Botanical Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Botanical Drug Players by Revenue
3.1.1 Global Top Botanical Drug Players by Revenue (2019-2024)
3.1.2 Global Botanical Drug Revenue Market Share by Players (2019-2024)
3.2 Global Botanical Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Botanical Drug Revenue
3.4 Global Botanical Drug Market Concentration Ratio
3.4.1 Global Botanical Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Botanical Drug Revenue in 2023
3.5 Botanical Drug Key Players Head office and Area Served
3.6 Key Players Botanical Drug Product Solution and Service
3.7 Date of Enter into Botanical Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Botanical Drug Breakdown Data by Type
4.1 Global Botanical Drug Historic Market Size by Type (2019-2024)
4.2 Global Botanical Drug Forecasted Market Size by Type (2025-2030)
5 Botanical Drug Breakdown Data by Application
5.1 Global Botanical Drug Historic Market Size by Application (2019-2024)
5.2 Global Botanical Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Botanical Drug Market Size (2019-2030)
6.2 North America Botanical Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Botanical Drug Market Size by Country (2019-2024)
6.4 North America Botanical Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Botanical Drug Market Size (2019-2030)
7.2 Europe Botanical Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Botanical Drug Market Size by Country (2019-2024)
7.4 Europe Botanical Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Botanical Drug Market Size (2019-2030)
8.2 Asia-Pacific Botanical Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Botanical Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Botanical Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Botanical Drug Market Size (2019-2030)
9.2 Latin America Botanical Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Botanical Drug Market Size by Country (2019-2024)
9.4 Latin America Botanical Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Botanical Drug Market Size (2019-2030)
10.2 Middle East & Africa Botanical Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Botanical Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Botanical Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Buchang Pharmaceuticals
11.1.1 Buchang Pharmaceuticals Company Detail
11.1.2 Buchang Pharmaceuticals Business Overview
11.1.3 Buchang Pharmaceuticals Botanical Drug Introduction
11.1.4 Buchang Pharmaceuticals Revenue in Botanical Drug Business (2019-2024)
11.1.5 Buchang Pharmaceuticals Recent Development
11.2 China TCM
11.2.1 China TCM Company Detail
11.2.2 China TCM Business Overview
11.2.3 China TCM Botanical Drug Introduction
11.2.4 China TCM Revenue in Botanical Drug Business (2019-2024)
11.2.5 China TCM Recent Development
11.3 Tsumura
11.3.1 Tsumura Company Detail
11.3.2 Tsumura Business Overview
11.3.3 Tsumura Botanical Drug Introduction
11.3.4 Tsumura Revenue in Botanical Drug Business (2019-2024)
11.3.5 Tsumura Recent Development
11.4 Schwabe
11.4.1 Schwabe Company Detail
11.4.2 Schwabe Business Overview
11.4.3 Schwabe Botanical Drug Introduction
11.4.4 Schwabe Revenue in Botanical Drug Business (2019-2024)
11.4.5 Schwabe Recent Development
11.5 Tong Ren Tang
11.5.1 Tong Ren Tang Company Detail
11.5.2 Tong Ren Tang Business Overview
11.5.3 Tong Ren Tang Botanical Drug Introduction
11.5.4 Tong Ren Tang Revenue in Botanical Drug Business (2019-2024)
11.5.5 Tong Ren Tang Recent Development
11.6 Jumpcan Pharmaceutical
11.6.1 Jumpcan Pharmaceutical Company Detail
11.6.2 Jumpcan Pharmaceutical Business Overview
11.6.3 Jumpcan Pharmaceutical Botanical Drug Introduction
11.6.4 Jumpcan Pharmaceutical Revenue in Botanical Drug Business (2019-2024)
11.6.5 Jumpcan Pharmaceutical Recent Development
11.7 Guangzhou Baiyunshan Pharmaceutical
11.7.1 Guangzhou Baiyunshan Pharmaceutical Company Detail
11.7.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
11.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Introduction
11.7.4 Guangzhou Baiyunshan Pharmaceutical Revenue in Botanical Drug Business (2019-2024)
11.7.5 Guangzhou Baiyunshan Pharmaceutical Recent Development
11.8 Yunnan Baiyao
11.8.1 Yunnan Baiyao Company Detail
11.8.2 Yunnan Baiyao Business Overview
11.8.3 Yunnan Baiyao Botanical Drug Introduction
11.8.4 Yunnan Baiyao Revenue in Botanical Drug Business (2019-2024)
11.8.5 Yunnan Baiyao Recent Development
11.9 Tasly Holding Group
11.9.1 Tasly Holding Group Company Detail
11.9.2 Tasly Holding Group Business Overview
11.9.3 Tasly Holding Group Botanical Drug Introduction
11.9.4 Tasly Holding Group Revenue in Botanical Drug Business (2019-2024)
11.9.5 Tasly Holding Group Recent Development
11.10 Bionorica Se
11.10.1 Bionorica Se Company Detail
11.10.2 Bionorica Se Business Overview
11.10.3 Bionorica Se Botanical Drug Introduction
11.10.4 Bionorica Se Revenue in Botanical Drug Business (2019-2024)
11.10.5 Bionorica Se Recent Development
11.11 Huarun 999
11.11.1 Huarun 999 Company Detail
11.11.2 Huarun 999 Business Overview
11.11.3 Huarun 999 Botanical Drug Introduction
11.11.4 Huarun 999 Revenue in Botanical Drug Business (2019-2024)
11.11.5 Huarun 999 Recent Development
11.12 Taiji
11.12.1 Taiji Company Detail
11.12.2 Taiji Business Overview
11.12.3 Taiji Botanical Drug Introduction
11.12.4 Taiji Revenue in Botanical Drug Business (2019-2024)
11.12.5 Taiji Recent Development
11.13 Weleda
11.13.1 Weleda Company Detail
11.13.2 Weleda Business Overview
11.13.3 Weleda Botanical Drug Introduction
11.13.4 Weleda Revenue in Botanical Drug Business (2019-2024)
11.13.5 Weleda Recent Development
11.14 Kwangdong
11.14.1 Kwangdong Company Detail
11.14.2 Kwangdong Business Overview
11.14.3 Kwangdong Botanical Drug Introduction
11.14.4 Kwangdong Revenue in Botanical Drug Business (2019-2024)
11.14.5 Kwangdong Recent Development
11.15 GW Pharmaceuticals
11.15.1 GW Pharmaceuticals Company Detail
11.15.2 GW Pharmaceuticals Business Overview
11.15.3 GW Pharmaceuticals Botanical Drug Introduction
11.15.4 GW Pharmaceuticals Revenue in Botanical Drug Business (2019-2024)
11.15.5 GW Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Botanical Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Prescription Drug
Table 3. Key Players of OTC
Table 4. Global Botanical Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Botanical Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Botanical Drug Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Botanical Drug Market Share by Region (2019-2024)
Table 8. Global Botanical Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Botanical Drug Market Share by Region (2025-2030)
Table 10. Botanical Drug Market Trends
Table 11. Botanical Drug Market Drivers
Table 12. Botanical Drug Market Challenges
Table 13. Botanical Drug Market Restraints
Table 14. Global Botanical Drug Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Botanical Drug Market Share by Players (2019-2024)
Table 16. Global Top Botanical Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Botanical Drug as of 2023)
Table 17. Ranking of Global Top Botanical Drug Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Botanical Drug Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Botanical Drug Product Solution and Service
Table 21. Date of Enter into Botanical Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Botanical Drug Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Botanical Drug Revenue Market Share by Type (2019-2024)
Table 25. Global Botanical Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Botanical Drug Revenue Market Share by Type (2025-2030)
Table 27. Global Botanical Drug Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Botanical Drug Revenue Market Share by Application (2019-2024)
Table 29. Global Botanical Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Botanical Drug Revenue Market Share by Application (2025-2030)
Table 31. North America Botanical Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Botanical Drug Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Botanical Drug Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Botanical Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Botanical Drug Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Botanical Drug Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Botanical Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Botanical Drug Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Botanical Drug Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Botanical Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Botanical Drug Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Botanical Drug Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Botanical Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Botanical Drug Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Botanical Drug Market Size by Country (2025-2030) & (US$ Million)
Table 46. Buchang Pharmaceuticals Company Detail
Table 47. Buchang Pharmaceuticals Business Overview
Table 48. Buchang Pharmaceuticals Botanical Drug Product
Table 49. Buchang Pharmaceuticals Revenue in Botanical Drug Business (2019-2024) & (US$ Million)
Table 50. Buchang Pharmaceuticals Recent Development
Table 51. China TCM Company Detail
Table 52. China TCM Business Overview
Table 53. China TCM Botanical Drug Product
Table 54. China TCM Revenue in Botanical Drug Business (2019-2024) & (US$ Million)
Table 55. China TCM Recent Development
Table 56. Tsumura Company Detail
Table 57. Tsumura Business Overview
Table 58. Tsumura Botanical Drug Product
Table 59. Tsumura Revenue in Botanical Drug Business (2019-2024) & (US$ Million)
Table 60. Tsumura Recent Development
Table 61. Schwabe Company Detail
Table 62. Schwabe Business Overview
Table 63. Schwabe Botanical Drug Product
Table 64. Schwabe Revenue in Botanical Drug Business (2019-2024) & (US$ Million)
Table 65. Schwabe Recent Development
Table 66. Tong Ren Tang Company Detail
Table 67. Tong Ren Tang Business Overview
Table 68. Tong Ren Tang Botanical Drug Product
Table 69. Tong Ren Tang Revenue in Botanical Drug Business (2019-2024) & (US$ Million)
Table 70. Tong Ren Tang Recent Development
Table 71. Jumpcan Pharmaceutical Company Detail
Table 72. Jumpcan Pharmaceutical Business Overview
Table 73. Jumpcan Pharmaceutical Botanical Drug Product
Table 74. Jumpcan Pharmaceutical Revenue in Botanical Drug Business (2019-2024) & (US$ Million)
Table 75. Jumpcan Pharmaceutical Recent Development
Table 76. Guangzhou Baiyunshan Pharmaceutical Company Detail
Table 77. Guangzhou Baiyunshan Pharmaceutical Business Overview
Table 78. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product
Table 79. Guangzhou Baiyunshan Pharmaceutical Revenue in Botanical Drug Business (2019-2024) & (US$ Million)
Table 80. Guangzhou Baiyunshan Pharmaceutical Recent Development
Table 81. Yunnan Baiyao Company Detail
Table 82. Yunnan Baiyao Business Overview
Table 83. Yunnan Baiyao Botanical Drug Product
Table 84. Yunnan Baiyao Revenue in Botanical Drug Business (2019-2024) & (US$ Million)
Table 85. Yunnan Baiyao Recent Development
Table 86. Tasly Holding Group Company Detail
Table 87. Tasly Holding Group Business Overview
Table 88. Tasly Holding Group Botanical Drug Product
Table 89. Tasly Holding Group Revenue in Botanical Drug Business (2019-2024) & (US$ Million)
Table 90. Tasly Holding Group Recent Development
Table 91. Bionorica Se Company Detail
Table 92. Bionorica Se Business Overview
Table 93. Bionorica Se Botanical Drug Product
Table 94. Bionorica Se Revenue in Botanical Drug Business (2019-2024) & (US$ Million)
Table 95. Bionorica Se Recent Development
Table 96. Huarun 999 Company Detail
Table 97. Huarun 999 Business Overview
Table 98. Huarun 999 Botanical Drug Product
Table 99. Huarun 999 Revenue in Botanical Drug Business (2019-2024) & (US$ Million)
Table 100. Huarun 999 Recent Development
Table 101. Taiji Company Detail
Table 102. Taiji Business Overview
Table 103. Taiji Botanical Drug Product
Table 104. Taiji Revenue in Botanical Drug Business (2019-2024) & (US$ Million)
Table 105. Taiji Recent Development
Table 106. Weleda Company Detail
Table 107. Weleda Business Overview
Table 108. Weleda Botanical Drug Product
Table 109. Weleda Revenue in Botanical Drug Business (2019-2024) & (US$ Million)
Table 110. Weleda Recent Development
Table 111. Kwangdong Company Detail
Table 112. Kwangdong Business Overview
Table 113. Kwangdong Botanical Drug Product
Table 114. Kwangdong Revenue in Botanical Drug Business (2019-2024) & (US$ Million)
Table 115. Kwangdong Recent Development
Table 116. GW Pharmaceuticals Company Detail
Table 117. GW Pharmaceuticals Business Overview
Table 118. GW Pharmaceuticals Botanical Drug Product
Table 119. GW Pharmaceuticals Revenue in Botanical Drug Business (2019-2024) & (US$ Million)
Table 120. GW Pharmaceuticals Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Botanical Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Botanical Drug Market Share by Type: 2023 VS 2030
Figure 3. Prescription Drug Features
Figure 4. OTC Features
Figure 5. Global Botanical Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Botanical Drug Market Share by Application: 2023 VS 2030
Figure 7. Cardiovascular Case Studies
Figure 8. Tumor Case Studies
Figure 9. Respiratory System Case Studies
Figure 10. Other Case Studies
Figure 11. Botanical Drug Report Years Considered
Figure 12. Global Botanical Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Botanical Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Botanical Drug Market Share by Region: 2023 VS 2030
Figure 15. Global Botanical Drug Market Share by Players in 2023
Figure 16. Global Top Botanical Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Botanical Drug as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Botanical Drug Revenue in 2023
Figure 18. North America Botanical Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Botanical Drug Market Share by Country (2019-2030)
Figure 20. United States Botanical Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Botanical Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Botanical Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Botanical Drug Market Share by Country (2019-2030)
Figure 24. Germany Botanical Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Botanical Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Botanical Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Botanical Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Botanical Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Botanical Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Botanical Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Botanical Drug Market Share by Region (2019-2030)
Figure 32. China Botanical Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Botanical Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Botanical Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Botanical Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Botanical Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Botanical Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Botanical Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Botanical Drug Market Share by Country (2019-2030)
Figure 40. Mexico Botanical Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Botanical Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Botanical Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Botanical Drug Market Share by Country (2019-2030)
Figure 44. Turkey Botanical Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Botanical Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Buchang Pharmaceuticals Revenue Growth Rate in Botanical Drug Business (2019-2024)
Figure 47. China TCM Revenue Growth Rate in Botanical Drug Business (2019-2024)
Figure 48. Tsumura Revenue Growth Rate in Botanical Drug Business (2019-2024)
Figure 49. Schwabe Revenue Growth Rate in Botanical Drug Business (2019-2024)
Figure 50. Tong Ren Tang Revenue Growth Rate in Botanical Drug Business (2019-2024)
Figure 51. Jumpcan Pharmaceutical Revenue Growth Rate in Botanical Drug Business (2019-2024)
Figure 52. Guangzhou Baiyunshan Pharmaceutical Revenue Growth Rate in Botanical Drug Business (2019-2024)
Figure 53. Yunnan Baiyao Revenue Growth Rate in Botanical Drug Business (2019-2024)
Figure 54. Tasly Holding Group Revenue Growth Rate in Botanical Drug Business (2019-2024)
Figure 55. Bionorica Se Revenue Growth Rate in Botanical Drug Business (2019-2024)
Figure 56. Huarun 999 Revenue Growth Rate in Botanical Drug Business (2019-2024)
Figure 57. Taiji Revenue Growth Rate in Botanical Drug Business (2019-2024)
Figure 58. Weleda Revenue Growth Rate in Botanical Drug Business (2019-2024)
Figure 59. Kwangdong Revenue Growth Rate in Botanical Drug Business (2019-2024)
Figure 60. GW Pharmaceuticals Revenue Growth Rate in Botanical Drug Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
